Sort
10,766 grants matching “checkpoint inhibitor”
New Approaches to Modeling and Targeting Cyclin E-amplified High-Grade Serous Tubo-Ovarian Carcinoma
$689,255Benjamin G. Neel · New York University School Of Medicine · R01 · FY2022 · CA
New Approaches to Modeling and Targeting Cyclin E-amplified High-Grade Serous Tubo-Ovarian Carcinoma
$689,255Benjamin G. Neel · New York University School Of Medicine · R01 · FY2023 · CA
Interrogating Mechanisms of Anti-tumor Immunity in Human Subjects and Murine Models of IDH-Mutant Glioma Treated with All-Trans Retinoic Acid and PD-1 Inhibition
$689,044Nduka Mgbechinyere Amankulor · University Of Pennsylvania · R37 · FY2024 · CA
Systems analysis of cell-cell communication networks and immune activity in the melanoma tumor microenvironment
$688,917Kathryn Miller-Jensen · Yale University · U01 · FY2021 · CA
Clinical trials employing cancer vaccine combination therapies
$688,838James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$688,838James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
A physical sciences approach to investigate the role of exosomes in metastatic progression
$688,299Ravi Radhakrishnan · University Of Pennsylvania · U01 · FY2021 · CA
Eco-Evolutionary dynamics of NSCLC to immunotherapy: Response and Resistance
$688,043Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2018 · CA
Response and resistance to SHP2 inhibitors alone and in combination in Non-Small Cell Lung Cancer
$688,018Benjamin G. Neel · New York University School Of Medicine · R01 · FY2023 · CA
Response and resistance to SHP2 inhibitors alone and in combination in Non-Small Cell Lung Cancer
$688,018Benjamin G. Neel · New York University School Of Medicine · R01 · FY2022 · CA
Myeloid cell-selective, oligonucleotide-based STAT3 inhibition combined with total marrow and lymphoid irradiation for immunotherapy of acute myeloid leukemia
$687,979Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Mechanisms of JAG1-mediated immune suppression in the pancreatic cancer microenvironment
$687,824Lan Zhou · Methodist Hospital Research Institute · R01 · FY2024 · CA
Understanding and Targeting Transcriptional Master Regulators in Hepatocellular Carcinoma
$687,679Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2025 · CA
A novel preclinical model of spontaneous metastasis
$686,928Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Elucidating T Cell Ferroptosis in Renal Medullary Carcinoma: 3D Genome Architecture Rewiring and Therapeutic Alleviation
$686,919Liuqing Yang · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
A prospective evaluation of the gut microbiome as a mediator of lymphoma treatment outcome and systemic immunity
$686,548Catherine Sibyl Diefenbach · New York University School Of Medicine · R01 · FY2023 · CA
Targeting the CD73-adenosinergic pathway in head and neck cancer
$686,127Yan Cui · Augusta University · R01 · FY2023 · DE
Small extracellular vesicles as biomarkers of prognosis and response to therapy in head and neck cancer
$686,036Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DE
Administrative Core
$685,965Jun Yan · University Of Louisville · P20 · FY2023 · GM
Targeting natural killer cells to enhance HIV vaccine responses
$685,580Stephen N. Waggoner · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · AI
Mechanisms of Immune Dysfunction and Morbid Outcome in Response to Shock/Sepsis
$684,885Alfred Ayala · Rhode Island Hospital · R35 · FY2020 · GM
Intratumoral microbiota and immune predictors of response to immunotherapy in lung cancer
$684,367Yanhong Liu · Baylor College Of Medicine · R01 · FY2024 · CA
Implications of Changes in Islet Exosomal Cargo in Type 1 Diabetes
$684,254Emily K Sims · Indiana University Indianapolis · R01 · FY2023 · DK
Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation
$683,986Cheryl A London · Tufts University Boston · U01 · FY2024 · CA
DNA repair gene mutations and prostate cancer
$683,795Binghui Shen · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA